MAPT and Alzheimer disease: Research by Knorr et al. (2022) suggests that variations in cerebrospinal fluid markers during emotional relapses, specifically increased a Aβ42 and decreased hyperphosphorylated tau, could contribute to cognitive deterioration and a higher AD risk in BD patients AD related biomarkers in BD—A longitudinal one-year case–control study.